retroperitoneal liposarcoma
Showing 1 - 25 of 237
Status of Surgical Resection and Histologic Subtype as
Completed
- Liposarcoma of Soft Tissue
- Surgical Procedure, Unspecified
- Retroperitoneal Liposarcoma resection
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da Universidade d
Jun 18, 2022
Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)
Recruiting
- Liposarcoma
- +5 more
- Eribulin Mesylate
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Oct 17, 2022
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma Trial in Worldwide (Surgery, Preoperative chemo)
Recruiting
- Retroperitoneal Sarcoma
- +2 more
- Surgery
- Preoperative chemotherapy
-
Woolloongabba, Queensland, Australia
- +36 more
Dec 27, 2022
Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,
Recruiting
- Leiomyosarcoma
- +29 more
- Definitive Surgical Resection
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022
Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma Trial in France, Italy, Spain (Trabectedin, Radiotherapy)
Recruiting
- Liposarcoma, Myxoid
- +4 more
- Trabectedin
- Radiotherapy
-
Bordeaux, France
- +15 more
Jun 6, 2022
Retroperitoneal Sarcoma Trial in Washington, Baltimore (Hypofractionated Proton Beam Therapy)
Not yet recruiting
- Retroperitoneal Sarcoma
- Hypofractionated Proton Beam Therapy
-
Washington, District of Columbia
- +1 more
Jul 15, 2022
Nutritional Status on Oncologic and Operative Outcome in
Recruiting
- Retroperitoneal Sarcoma
- +5 more
- Measurement of body composition with computed tomography (CT)
- +5 more
-
Ljubljana, SloveniaInstitute of Oncology Ljubljana
Dec 2, 2022
Liposarcoma, Atypical Lipomatous Tumor Trial in Montpellier (Blood sampling)
Recruiting
- Liposarcoma
- Atypical Lipomatous Tumor
- Blood sampling
-
Montpellier, FranceInstitut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022
Tumors Trial in United States (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)
Completed
- Neoplasms
- letetresgene autoleucel (GSK3377794)
- +2 more
-
Tampa, Florida
- +5 more
Oct 31, 2022
Engagement Patterns and Participation Trends Among Liposarcoma
Not yet recruiting
- Liposarcoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 8, 2023
Liposarcoma, Dedifferentiated Trial in Worldwide (BI 907828, Doxorubicin)
Recruiting
- Liposarcoma, Dedifferentiated
- BI 907828
- Doxorubicin
-
Birmingham, Alabama
- +131 more
Feb 2, 2023
Dedifferentiated Liposarcoma Patients in China
Not yet recruiting
- Dedifferentiated Liposarcoma
-
Beijing, ChinaBeijing Jishuitan hospital
Oct 30, 2023
Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)
Active, not recruiting
- Sarcoma, Soft Tissue
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 29, 2023
Retroperitoneal Sarcoma Trial in Seattle (drug, procedure, radiation)
Not yet recruiting
- Retroperitoneal Sarcoma
- Abemaciclib
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 5, 2023
Retroperitoneal Fibrosis Trial in Beijing (Sirolimus, Corticosteroid)
Recruiting
- Retroperitoneal Fibrosis
-
Beijing, Beijing, ChinaPeking University International Hospital
Dec 7, 2022
Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)
Active, not recruiting
- Liposarcoma
- Metastatic Liposarcoma
-
Boston, Massachusetts
- +2 more
Nov 23, 2022
Urologic Diseases, Surgery Trial (Laparoscopic pyeloplasty)
Not yet recruiting
- Urologic Diseases
- Surgery
- Laparoscopic pyeloplasty
- (no location specified)
Feb 28, 2023
Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)
Completed
- Dedifferentiated Liposarcoma
- Selinexor
- Placebo
-
Los Angeles, California
- +70 more
Jan 5, 2023
Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma
Not yet recruiting
- Advanced Dedifferentiated Liposarcoma
- +5 more
- Palbociclib
- +5 more
- (no location specified)
Jan 11, 2023
Dedifferentiated Liposarcoma Trial in Beijing, Shanghai (TQB3616 capsule, TQB3616 )
Not yet recruiting
- Dedifferentiated Liposarcoma
- TQB3616 capsule
- TQB3616 placebo
-
Beijing, Beijing, China
- +2 more
Aug 9, 2022
Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)
Not yet recruiting
- Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
- XELOX combined with Fruquintinib and Sintilimab
- (no location specified)
Oct 17, 2023
Pelvic Organ Prolapse Trial in Galveston (Tunneling Technique during RA SCP, Dissection Technique during RA SCP)
Recruiting
- Pelvic Organ Prolapse
- Tunneling Technique during RA SCP
- Dissection Technique during RA SCP
-
Galveston, TexasUniversity of Texas Medical Branch Galveston
Jul 28, 2023